EODData

MEMBERSHIP REGISTER LOG IN

ASX, ALA: Arovella Therapeutics Ltd.

16 Oct 2026
LAST:

0.0510

CHANGE:
 0.00		OPEN:
0.0550		HIGH:
0.0550		ASK:
0.0900		VOLUME:
150.5K
CHG(%):
2.00		PREV:
0.0500		LOW:
0.0510		BID:
0.0850		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
16 Oct 260.05500.05500.05100.0510150.5K
15 Oct 260.05300.05300.05000.05001.73M
14 Oct 260.05600.05600.05300.0530452.8K
13 Oct 260.05550.05700.05450.05702.51M
12 Oct 260.05200.05700.05100.0550811.6K
09 Oct 260.04800.05300.04800.05201.14M
08 Oct 260.04800.04800.04700.0480595.0K
07 Oct 260.04700.04800.04600.0480485.5K
06 Oct 260.04700.04750.04700.0470282.0K
05 Oct 260.04750.04800.04700.0480109.4K

PROFILE

Name:Arovella Therapeutics Ltd.
About:Arovella Therapeutics Limited, a biotechnology company, focuses on the development of therapies for the treatment of cancer in Australia and internationally. The company product pipeline includes ALA-101 CD19, which is a next-generation off-the-shelf CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukaemias; ALA-105 CLDN18.2 for targeting Claudin 18.2, which is expressed in gastric cancer, gastroesophageal junction cancer, pancreatic cancer, and lung and ovarian cancer; and IL-12-TM for treating solid tumors. Its ALA-101 product entered first-in-human phase 1 clinical trial. The company was formerly known as Suda Pharmaceuticals Ltd and changed its name to Arovella Therapeutics Limited in October 2021. Arovella Therapeutics Limited was incorporated in 1999 and is based in Preston, Australia.
Sector:Healthcare
Industry:Biotechnology
Address:Corporate One, Preston, VIC, Australia, 3072
Website:https://www.arovella.com
ISIN:AU0000182784
FIGI:BBG000L6NZF3

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-9.83 
Forward P/E:-5.50 
PEG Ratio:-5.50 
Price to Sales:19.01 
Price to Book:4.58 
Profit Margin:-1.98 
Operating Margin:-18.75 
Return on Assets:-0.26 
Return on Equity:-0.40 
EPS Ratio:-0.01 
Revenue:3.5M 
Shares:1.209B 
Market Cap:61.65M 

TECHNICAL INDICATORS

MA5:0.054.3%
MA10:0.050.2%
MA20:0.050.6%
MA50:0.0612.2%
MA100:0.0620.8%
MA200:0.0739.4%
STO9:40.00
STO14:40.00
RSI14:54.55
WPR14:-60.00
MTM14:0.00
ROC14:0.06 
ATR:0.00 
Week High:0.0611.8%
Week Low:0.056.3%
Month High:0.0621.6%
Month Low:0.0539.4%
Year High:0.1096.1%
Year Low:0.0510.9%

RECENT SPLITS

Date Ratio
13 Nov 20191-25
01 Jun 20091-1

RECENT DIVIDENDS

Date Amount
16 Jun 2025$0.32